Bio-Rad Laboratories, Inc. (NYSE:BIO) agreed to acquire Curiosity Diagnostics Sp. z o.o. from Scope Fluidics S.A. (WSE:SCP) for $100 million on August 3, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
164 PLN | -1.44% |
|
-1.20% | -16.33% |
![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
-16.33% | 116M | |
-32.86% | 8.68B | |
+25.06% | 3.86B | |
+15.74% | 2.43B | |
-26.46% | 1.84B | |
-7.09% | 1.73B | |
+40.61% | 1.16B | |
+54.75% | 842M | |
-9.17% | 702M | |
-9.18% | 594M |
- Stock Market
- Equities
- SCP Stock
- News Scope Fluidics S.A.
- Bio-Rad Laboratories, Inc. agreed to acquire Curiosity Diagnostics Sp. z o.o. from Scope Fluidics S.A. for $100 million.